DBT
REGN icon

Dubuque Bank & Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Dubuque Bank & Trust’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5
Closed -$2K – 511
2019
Q1 		$2K Buy
+5
New +$2.06K ﹤0.01% 665
2018
Q3 		– Sell
-2
Closed -$1K – 702
2018
Q2 		$1K Hold
2
– – ﹤0.01% 677
2018
Q1 		$1K Buy
+2
New +$696 ﹤0.01% 703

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dubuque Bank & Trust's REGN Position: Q2 2019 in Review

Dubuque Bank & Trust sold out of Regeneron Pharmaceuticals (REGN) in Q2 2019, closing a stake of 5 shares — an estimated $2K sold.

Dubuque Bank & Trust first reported a position in REGN in Q1 2018 and held it in 3 quarters. The position peaked at $2K in Q1 2019. 658 funds tracked by Wall St. Rank hold REGN as of Q2 2019.

  • Dubuque Bank & Trust reported no remaining Regeneron Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Dubuque Bank & Trust sold 5 Regeneron Pharmaceuticals shares in Q2 2019, an estimated $2K.
  • Dubuque Bank & Trust first reported a position in Regeneron Pharmaceuticals in Q1 2018 and held it in 3 quarters.
  • Dubuque Bank & Trust's Regeneron Pharmaceuticals position peaked at $2K in Q1 2019.
  • 658 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2019.

Based on Dubuque Bank & Trust's 13F filing for Q2 2019, filed 10 Jul 2019.